Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

Drug Channels News Roundup, March 2026: Cigna’s 340B Workaround, Merck’s ARPA Surprise, Walgreens’ Automation Bet, Why Rebates Hurt Patients, and a DCI Team Photo

 March 31, 2026

Drug Channels

Spring is here in always-sunny Philadelphia.

OtherRead full story

Post navigation

Biotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026 →
← UCB brings first therapy for rare disease TK2d to EU

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com